Molnupiravir Could Be the First-Ever Pill to Treat Coronavirus

HealthMolnupiravir Could Be the First-Ever Pill to Treat Coronavirus

Its been almost two years since Coronavirus hit the entire circumference of the globe. With thousands of patients relentlessly dying in a small timeframe, the lethal virus has immensely affected the global social environment. While majority of the countries are vaccinating their citizens against the disease, it still seems uncertain as if the vaccine is competent enough to deal with Coronavirus. However, Merck and Ridgeback Biotherapeutics have applied for US authorization of their medicine Molnupiravir. This medicine has been greatly affective against Coronavirus. Upon successful authorization, Molnupiravir could be the first-ever pill to cure Coronavirus.

Merck Background

Merck & Co. is an American medicine company very-well known for pharmaceutical drugs, vaccines, and animal health products. The company became widely famous for making the first smallpox vaccine for commercial use in the US.

Ridgeback Biotherapeutics Background

Ridgeback Biotherapeutics surfaced on the face of pharmaceutical industry in 2016. The company is known for developing potential medications to treat infectious diseases that have limited or no treatment options.

What Will Happen After Approval?

If Molnupiravir gets approval by Food and Drug Administration, it would be the first pill to treat Coronavirus. It is worth mentioning that all the other FDA-backed treatments against the virus require an IV or injection.

What Does Molnupiravir Do?

It is an antiviral medicine that patients can take to minimize the affect and symptoms of Coronavirus. The pill also helps in speedy recovery of the patients suffering from the virus.

According to the senior vice president at Merck’s infectious disease unit, the medicine is a vital addition in treating Coronavirus as it minimizes the hurdles and cautions involved in infusion centres. Patients with mild to moderate symptoms can take the pill at their homes and feel better without having to reach the infusion facilities. Dr. Nicholas Kartsonis said, “The value here is that it’s a pill so you don’t have to deal with the infusion centers and all the factors around that. I think it’s a very powerful tool to add to the toolbox”.

Talal Farooqi
Talal Farooqi
A mass media grad with a great deal of interest in blogging and copywriting. I hear that I'm good with words. So, feel free to check out my work!

Must read

Recent News

Mr Imran Khan this was you who gave extension to former COAS alone instead of other chiefs

Mr Imran Khan this was you who gave an extension to former COAS alone...

0
Islamabad, Pakistan: The jailed former Prime Minister Imran Khan has said that the extension (of Army chief) made institutions weaker rather than making them...

Does close partnership between China and Pakistan provide immunity to attack Chinese citizens?

0
Islamabad, Pakistan: There is no doubt that Pakistan and China are close partners and iron brothers, united by a bond of mutual respect and...

Kidnapping of Pakistani youths in Thailand

0
Monitoring Desk: Two more young boys from Pakistan are kidnapped in Thailand but the government of Pakistan is silent over such incidents.The entire Pakistan,...
Pakistan Minority Forum

Pakistan Minority Forum Calls for Urgent Action on Minority Rights: “Promises Must Be Honored”

0
Sahiwal, Pakistan: A powerful seminar held at the Arts Council Sahiwal, hosted by the Sahiwal Minority Forum Pakistan, brought together prominent political and social...
“Ustad Bashiruddin- A Restrained Grace” and “Bleeding Borders”

“Ustad Bashiruddin- A Restrained Grace” and “Bleeding Borders”

0
Lahore, Pakistan: In connection with the celebrations marking 150 years of Mayo School of Arts and National College of Arts, Lahore, Pakistan, the opening...
Advertisement